 unit emitted a strong musk that was sex distilled. Another thing all you superheroes have.  Both hands were required now, the member brought fully to life; bulbous head mere inches from my face. Occasionally the tip would tap Catwoman’s nose as it passed, leaving behind trails of precum.
Selina couldn’t resist any longer, letting her tongue lash out: tentatively at first. She dabbled at the member.  Selina eased in further, peppering the phallus with licks that devolved into kisses. Catwoman’s hands continued to stroke the member, pleasuring it as Peter grunted with pleasure.
The head of the cock stared right at her.  No doubt there was cum staining her outfit, but Selina didn't mind. Selina pressed forward, once again slathering the purple crown with her tongue until it glistened. Good and slick, her hands easily slid up and down the cock; coaxing bits of pre and pleasure from the restrained hero. The pre mixed with her spittle, allowing her to go faster and faster; the monolithic member bucking up and down within her grip.
 Her jaw hurt from the effort; Peter’s cock was at least as big around as it was long, and Selina’s previous experience with something even close to this massive was at a sandwich shop. Selina was not going to disappoint. With great effort Selina pressed onward, trying to relax her throat while feeding more of the hero's gift inside.
 Selina can only imagine how she looked with Spiderman’s cock bulging out her gullet.  Yet his subtle urging was willing her to accept more until Catwoman’s nose pressed against the base of his cock.   Letting inch after inch slide free. It continued for several moments until Selina became impatient.
What began as a gentle pull was becoming a pistoning action. The cock going in and out. Selina managed to pull so far out the crown of the cockhead would bang into her jaw before returning; her nose would press into Spiderman’s groin. Peter clenched hard against his prison; once again only succeeding in rocking his body laterally. Catwoman slowed down her sensuous work and glanced up at him. Even though she couldn’t speak he could tell a rebuke was on her lips. Selina waggled her finger as if to say ‘Remember the rules.’ Spiderman gulped and tried to relax. 
 Her mouth massaged his member in long strokes while her hands teased his overblown balls. They tingled with pleasure as she fondled his nuts. Sometimes she’d pick them up and drop them; letting them plop onto his thighs with a large slap. Other times Catwoman would rub them with her fingers; finding spots that Peter didn’t know existed. Through all the action, Peter felt cum bubbling inside him; the wall he built up to cumming was no longer present; knocked down by Selina’s full red lips and deft touch. He grunted once; entire body shaking in warning.
Selina was way ahead of him.  From there she circled it around, causing the head to hit every single edge. Catwoman managed the maneuver twice before Peter's body responded. The shaking intensified and Peter managed a brief gasp of air; mouthing the word 'cum' under his shaky breath.
Catwoman reacted with a gusto not seen by his previous dalliances. In one smooth motion, she took the entire 13-inch length of his member down to the hilt.  How long had it been since he'd cum? He had no idea. All Peter knew now was that every single drop was being launched against the otherworldly thief and she was greedily sucking it all down.
Albert Maysles, the documentarian, has died aged 88.
He passed away on Thursday, March 5 from natural causes.
Along with his brother David, Albert Maysles was one of the great documentary filmmakers of the Sixties and Seventies.
The Maysles brothers’ filmed both The Beatles and the Rolling Stones, among many other subjects.
In 1964, the Maysles followed The Beatles on their first American tour for a documentary titled What’s Happening! The Beatles In The U.S.A.
Gimme Shelter, meanwhile, they followed the Stones on the band’s infamous 1969 tour of the States, which culminated with the free concert at Altamont Speedway.
Outside of music, Albert and David Maysles shot documentaries on Orson Welles, Marlon Brando and, in 1975, Grey Gardens, a mother and daughter both named Edith Beale who were aunt and cousin of Jacqueline Kennedy Onassis.
A restored version of Grey Gardens has recently been released in American cinemas.
Following David’s death in 1987, Albert continued to make documentaries, including 2001’s Oscar-nominated LaLee’s Kin: The Legacy Of Cotton, about an impoverished African-American family living in the souther, of the United States.Douglas Cooper, London; to [Mayor Gallery, London], sold; to Mr. and Mrs. Harold Gershinowitz, New York, New York, 1953, gift; to Fogg Art Museum, 1960.
NOTE: Provenance from letter in curatorial file, Harold Gershinowitz to John P. Coolidge, dated 5 February 1960.
"Composition (Fernand Léger), 1960.90,” Harvard Art Museums collections online, Sep 26, 2021, https://hvrd.art/o/227566.Erratum to: Adolescent Participation in HPV Vaccine Clinical Trials: Are Parents Willing?

in HPV vaccine clinical trials (30.7% African American and 48.3% Caucasian, p =.081). African Americans had lower HPV vaccine awareness (p =.006) but not lower intentions to vaccinate (p =.086). Parental willingness was positively associated with the following variables: Child’s age (p <.039), Perceived Advantages of HPV Vaccination for Adolescents (p =.002), Parental Trust in Medical Researchers (p <.001), and Level of Ease in Understanding Clinical Trial Information (p =.010). Educating parents about the advantages of HPV vaccines for younger adolescents using low-literacy educational materials and building trust between parents and researchers may increase parental willingness to consent to adolescent participation in HPV vaccine clinical trials.

infection are comparable for males and females [7]. High HPV infection among adolescents makes them an appropriate target for prevention of HPV-related cancers.
The clinical trials that evaluated efficacy of three HPV vaccines (Cervarix, Gardasil-4, and Gardasil-9) for primary prevention against HPV infections were conducted in adolescents and young adults aged 16-26 years [8][9][10][11]. Although Cervarix and Gardasil-4 are no longer being marketed in the U.S., the trial findings demonstrated all three vaccines were highly efficacious against the targeted HPV types and associated sequelae. Cervarix and Gardasil-4 vaccines protected against two HPV types (16 and 18) that are responsible for 70 percent of cervical cancers, and Gardasil-9 protects against seven HPV types (16,18,31,33,45,52,58) causing nearly 90 percent of cervical cancers. Preadolescents and adolescents were not recruited to participate in these initial studies that led to vaccine approval due to legal and ethical issues (i.e. sexual activity evaluations and low exposure of HPV) [12]. To address this limitation, subsequent immunogenicity studies were conducted in adolescents aged 9-15 in order to bridge vaccine efficacy findings [12]. In fact, recent evidence of a greater immune response among 9-15 year olds with two doses of Gardasil-9 at least 5 months apart, compared to older ages with three doses, led to revision of the HPV vaccine guidelines in the U.S. in 2016. The current recommendation is for children aged 9-14 years to receive the HPV vaccine in two doses, while those starting the vaccine series at age 15 or older still require three doses [13].
While findings of these international studies demonstrated that the vaccine was efficacious and safe and induced higher immunogenicity under age 15 [12,[14][15][16], Black participation in these studies was disproportionately low compared to other racial groups [17,18]. For example, among adolescents aged 9-15 participating in the Gardasil-9 immunobridging clinical trials internationally, only 5.4% were Black compared to 19.2% multi-racial, 13.5% Asian, and 62.0% Caucasian [18]. Prior research suggests that distribution of infection from the various HPV types differs across racial/ethnic groups and global geographic regions [19][20][21]. Thus, participation of diverse adolescents in future HPV vaccine clinical trials would help ensure the development of new HPV vaccine formulations and guidelines that will optimally benefit all racial/ethnic groups and geographic regions. Emerging preliminary data suggest that one dose of the HPV vaccine could potentially produce a sufficient immune response [22][23][24][25]. A clinical trial was conducted in Costa Rica to determine immunogenicity of a single-dose, with plans to conduct a subsequent confirmatory trial in the U.S. [26,27]. Therefore, there is a need to develop mechanisms to improve participation of raciallyand ethnically-diverse adolescents in these future trials.
Parents or legal guardians must give consent for an adolescent child to participate in vaccine clinical trials [28]. The pediatric literature is deficient in identifying factors that influence parents' willingness to provide consent for their children to enroll